The global ticagrelor market was estimated at USD 1,422 million in 2021 and is expected to hit USD 2,254 million by 2028, registering a CAGR of 6.8% from 2022 to 2028 as per the latest report by Gen Consulting Company.
This industry report offers market estimates of the global market, followed by a detailed analysis of the dosage, route of administration, application, end user, and region. The global market data on ticagrelor can be segmented by dosage: 90mg, 60mg. Ticagrelor market is further segmented by route of administration: nasogastric tube, oral. Based on application, the ticagrelor market is segmented into: acute coronary syndrome, cardiac surgery. On the basis of end user, the ticagrelor market also can be divided into: ambulatory surgery centers (ASCs), hospitals & clinics, others. Ticagrelor market by region is categorized into: North America, Asia Pacific, Europe, Rest of the World (ROW).
The competitive landscape of the market is highly consolidated and dominated by key players such as AstraZeneca plc.
The data-centric report focuses on market trends, status and outlook for segments. With comprehensive market assessment across the major geographies, the report is a valuable asset for the existing players, new entrants and the future investors.
Why buy this report?
- Get a detailed picture of the Global Ticagrelor Market
- Identify segments/areas to invest in over the forecast period in the Global Ticagrelor Market
- Understand the competitive environment, the market's leading players
- The market estimate for ease of analysis across scenarios in Excel format.
- Strategy consulting and research support for three months.
- Print authentication provided for the single-user license.
Part 1. Summary
Part 2. Introduction
· Study period
· Geographical scope
· Market segmentation
Part 3. Ticagrelor market overview
Part 4. Market breakdown by dosage
· 90mg
· 60mg
Part 5. Market breakdown by route of administration
· Nasogastric tube
· Oral
Part 6. Market breakdown by application
· Acute coronary syndrome
· Cardiac surgery
Part 7. Market breakdown by end user
· Ambulatory surgery centers (ASCs)
· Hospitals & clinics
· Others
Part 8. Market breakdown by region
· North America
· Asia Pacific
· Europe
· Rest of the World (ROW)
Part 9. Key companies
· AstraZeneca plc
Part 10. Methodology
Overview of the Global Ticagrelor Intermediate Market:
The report discusses everything a marketer requires before investing in the global Ticagrelor Intermediate Market during the forecast period 2023-2030. It provi...
The global Ticagrelor market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field eva...
The global ticagrelor market was estimated at USD 1,422 million in 2021 and is expected to hit USD 2,254 million by 2028, registering a CAGR of 6.8% from 2022 to 2028 as per the latest report by Gen Consulting Company.
This industry report offers market estimates of the global market, f...
Summary
The report forecast global Ticagrelor market to grow to reach xxx Million USD in 2020 with a CAGR of xx% during the period 2021E-2026F due to coronavirus situation.
The report offers detailed coverage of Ticagrelor industry and main market trends with impact of coronavirus...
The Ticagrelor Market report offers perceptive information regarding drivers, restraints, opportunities, and trends of the Ticagrelor Market. With the use of historic data from (period), the Ticagrelor Market report offers Y-o-Y growth and CAGR until 2026. The insightful data offered in the ...